Therefore, exploring the impact of GLP-1/GLP-1R interaction or GLP-1 agonists on the human immune system would be interesting, which critically determines their wellbeing and resistance to diseases, including infections, cancers and other inflammatory diseases depending on gender and metabolic status. Here, GLP1R is linked to cancer.